Sasha King is Chief Marketing Officer of CareDx, Inc.. Currently has a direct ownership of 78,420 shares of CDNA, which is worth approximately $2.26 Million. The most recent transaction as insider was on Aug 09, 2022, when has been sold 31,298 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.4K
0% 3M change
0% 12M change
Total Value Held $2.26 Million

Sasha King Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2022
BUY
Grant, award, or other acquisition
-
31,298 Added 28.53%
78,420 Common Stock
Jun 01 2022
SELL
Payment of exercise price or tax liability
$109,847 $25.41 p/Share
4,323 Reduced 8.4%
47,122 Common Stock
Feb 03 2022
SELL
Payment of exercise price or tax liability
$22,846 $40.08 p/Share
570 Reduced 1.1%
51,445 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
14,150 Added 21.39%
52,015 Common Stock
Jan 29 2022
SELL
Payment of exercise price or tax liability
$30,885 $38.51 p/Share
802 Reduced 2.07%
37,865 Common Stock
Jan 25 2022
SELL
Payment of exercise price or tax liability
$31,474 $38.29 p/Share
822 Reduced 2.08%
38,667 Common Stock
Aug 06 2021
SELL
Payment of exercise price or tax liability
$17,694 $81.54 p/Share
217 Reduced 0.55%
39,489 Common Stock
Jul 06 2021
SELL
Payment of exercise price or tax liability
$39,243 $90.63 p/Share
433 Reduced 1.08%
39,706 Common Stock
Jun 09 2021
SELL
Open market or private sale
$1,119,274 $90.01 p/Share
12,435 Reduced 23.65%
40,139 Common Stock
Jun 09 2021
BUY
Exercise of conversion of derivative security
$34,930 $6.91 p/Share
5,055 Added 8.77%
52,574 Common Stock
Jun 08 2021
SELL
Open market or private sale
$90,020 $90.02 p/Share
1,000 Reduced 2.06%
47,519 Common Stock
Jun 08 2021
BUY
Exercise of conversion of derivative security
$12,680 $12.68 p/Share
1,000 Added 2.02%
48,519 Common Stock
Jun 07 2021
SELL
Open market or private sale
$726,471 $90.01 p/Share
8,071 Reduced 14.52%
47,519 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$171,509 $21.25 p/Share
8,071 Added 12.68%
55,590 Common Stock
Jun 01 2021
SELL
Payment of exercise price or tax liability
$495,988 $82.09 p/Share
6,042 Reduced 11.28%
47,519 Common Stock
Feb 25 2021
SELL
Payment of exercise price or tax liability
$247,291 $79.26 p/Share
3,120 Reduced 5.5%
53,561 Common Stock
Feb 25 2021
BUY
Grant, award, or other acquisition
-
8,000 Added 12.37%
56,681 Common Stock
Feb 03 2021
BUY
Grant, award, or other acquisition
-
6,750 Added 12.18%
48,681 Common Stock
Jan 29 2021
SELL
Payment of exercise price or tax liability
$52,813 $76.43 p/Share
691 Reduced 1.62%
41,931 Common Stock
Jan 25 2021
SELL
Payment of exercise price or tax liability
$69,331 $85.7 p/Share
809 Reduced 1.86%
42,622 Common Stock
Jan 14 2021
SELL
Open market or private sale
$857,743 $86.86 p/Share
9,875 Reduced 18.53%
43,431 Common Stock
Jan 14 2021
BUY
Exercise of conversion of derivative security
$79,691 $8.07 p/Share
9,875 Added 15.63%
53,306 Common Stock
Oct 08 2020
SELL
Open market or private sale
$2,064,030 $50.62 p/Share
40,775 Reduced 48.42%
43,431 Common Stock
Oct 08 2020
BUY
Exercise of conversion of derivative security
$208,037 $8.07 p/Share
25,779 Added 23.44%
84,206 Common Stock
SK

Sasha King

Chief Marketing Officer
Brisbane, CA

Track Institutional and Insider Activities on CDNA

Follow CareDx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDNA shares.

Notify only if

Insider Trading

Get notified when an Care Dx, Inc. insider buys or sells CDNA shares.

Notify only if

News

Receive news related to CareDx, Inc.

Track Activities on CDNA